Related Experiment Video
Updated: Jul 5, 2025
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.7K
First-in-Human Treatment of Severe Tricuspid Regurgitation Using a Novel Cross-Caval Heterotopic Device
Antonio Sisinni1,2, Rodrigo Estévez-Loureiro1,2, Berenice Caneiro-Queija1,2
1Department of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain.
JACC. Case Reports
|January 11, 2024
Abstract:
A 79-year-old woman, previously surgically treated for mitral and aortic valve replacement, experienced recurrent torrential tricuspid regurgitation after 2 transcatheter edge-to-edge repair procedures. Heart team assessment deemed the patient high risk for redo surgery and excluded transcatheter edge-to-edge repair and orthotopic replacement. The patient was then scheduled for a novel cross-caval device implantation.
